- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Esaote, Hitachi forge ultrasound alliance
Ultrasound developer Esaote, based in Genoa, Italy, has signed a letter of intent for a three-year technical and commercial cooperation agreement with Hitachi Medical. Pending regulatory approvals, the two firms will collaborate on new ultrasound
Ultrasound developer Esaote, based in Genoa, Italy, has signed a letter of intent for a three-year technical and commercial cooperation agreement with Hitachi Medical. Pending regulatory approvals, the two firms will collaborate on new ultrasound products and exchange technical information and components. Each company will continue to independently develop and market its existing product lines.
Both firms highlighted new ultrasound units at Decembers RSNA conference. Esaote introduced Technos, a premium ultrasound device designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, while Tarrytown, NY-based Hitachi unveiled Hitachi 6000, a work-in-progress unit that includes tissue harmonic imaging, directional CFA, and artifact suppression algorithms (SCAN 12/15/99 and 1/12/00).
In other Esaote news, the company released preliminary financial results for fiscal year 1999 (end-December), posting consolidated sales of $196.8 million, up 11% from 1998s $176.2 million. Sales in dedicated MRI climbed more than 60%, from $13.5 million in 1998 to $21.5 million in 1999, while the companys ultrasound sales were $112.7 million, up from $106.6 million the year before.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
